On Monday, the FDA sent 12 warning letters and five online advisory letters to the companies, saying that the products have not been reviewed by the agency and are not proven safe and effective to treat the diseases and health conditions they claim to treat.
The companies have 15 business days to explain how they will correct the alleged improper marketing.
“Simply put, health fraud scams prey on vulnerable populations, waste money and often delay proper medical care – and we will continue to take action to protect patients and caregivers from misleading, unproven products,” said FDA Commissioner Scott Gottlieb, MD.
In addition to the crackdown on dietary supplement makers, the agency will begin updating its oversight of the dietary supplement industry.
More articles on pharmacy:
Better pharmacy access sought for rural Colorado residents
Following its rival, Sanofi and Regeneron slash price of cholesterol drug by 60%
Mount Carmel’s chief pharmacy officer out amid overprescribing scandal
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.